Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
Werte in diesem Artikel
BELGRADE, Mont., Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.
Conference Details:
Conference Date: Tuesday, August 12, 2025
Conference Time: 8:30 AM ET
ConferenceDial-in: 877-545-0523
International Dial-in: 973-528-0016
Passcode: 482755
Conference Call Name: Xtant Medical Q2 2025 Financial Results
Webcast link: https://www.webcaster4.com/Webcast/Page/3039/52698
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-second-quarter-2025-financial-results-on-august-12-2025-302521141.html
SOURCE Xtant Medical Holdings, Inc.
Übrigens: Xtant Medical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Xtant Medical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Xtant Medical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Xtant Medical Holdings Inc Registered Shs
Analysen zu Xtant Medical Holdings Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
15.11.2018 | Xtant Medical Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
15.11.2018 | Xtant Medical Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Xtant Medical Holdings Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen